A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clnical Trial to Investigate the Efficacy and Safety of BMS-663068 in Heavily Treatment Experienced Subjects Infected with Multi-drug Resistant HIV-1

Administered By

Contributors

Start/End

  • July 1, 2015 - June 30, 2021